Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Jose Navia, MD

216.444.5104

Jose Navia, MD
Department: Thoracic and Cardiovascular Surgery
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code J4-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5104
DeskDesk:216.444.2480
WorkFax:216.445.3272
Jose Navia, MD
Department: Biomedical Engineering
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code J4-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5104
DeskDesk:216.444.2480
WorkFax:216.636.9987
Jose Navia, MD
Department: Transplantation Center
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code J4-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5104
DeskDesk:216.444.2480
WorkFax:216.636.9987
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

José L. Navia, MD, is a staff surgeon in the Department of Thoracic and Cardiovascular Surgery at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He specializes in adult-acquired heart disease, minimally invasive video-assisted cardiac surgery, off-pump coronary artery bypass surgery, minimally invasive mitral and aortic valve surgery, surgical electrical therapies for heart failure and arrhythmia surgery.

A native of Argentina, Dr. Navia is board certified to practice medicine and surgery in the United States by the Educational Commission for Foreign Medical Graduates in Philadelphia, Pennsylvania, and he holds Specialist Certificates in Cardiovascular Surgery and General Surgery in his native country. He earned his medical degree from the School of Medicine at the National University of La Plata in Buenos Aires, Argentina. He completed his internships and residencies in general surgery, cardiovascular surgery and cardiothoracic surgery in Argentinian hospitals.

He received a fellowship in cardiothoracic surgery from the Cleveland Clinic in 1994. During his fellowship and residency at Cleveland Clinic, Dr. Navia served as Chief Resident for one year. He has received the Rene Favaloro International Fellow Award and the Dr. Charles H. Bryan Clinical Excellence Award. He joined the Cleveland Clinic Heart and Vascular Institute in 1998 following an appointment at the Italian Hospital in Buenos Aires as staff surgeon in the Department of Thoracic and Cardiovascular Surgery.

In his work as a cardiothoracic and vascular surgeon, Dr. Navia plans and performs complex surgeries to treat a wide variety of cardiac disorders. Among his many awards is first prize at the National and International Meetings for Resident Physicians in General Surgery for his research project “Sensitivity and Specificity of Prognostic System in Acute Pancreatitis.” He was awarded another first prize by the National and Latin American Congress for Resident Physicians in General Surgery for “Choledoc Litasis Markers in Acute Gall Disease”.

Dr. Navia is a national leader in successfully and safely utilizing various techniques in minimally invasive off-pump bypass surgery. Currently, he is participating in the development of the Center for Electrical Therapies for Heart Failure. This Center’s mission is to advance cardiac resynchronization therapy and mechanical circulatory device therapy.

Dr. Navia has been a co-investigator for several clinical research trials. Dr. Navia’s research focuses on robotic cardiac surgery, video-assisted minimally invasive cardiac surgery, and a stentless mitral valve -- an original design for mitral valve replacement that is being used across the country. He has developed different cannulas (tubes for needles and surgical instruments) for pulmonary bypass and has designed a proximal anastomosis device to avoid clamping the aorta during cardiac surgery. He has also developed a percutaneous mitral valve ring and prosthesis. He is extensively involved in research to investigate new and more effective treatments for heart failure. Dr. Navia owns six patents and has four additional patents pending. He was awarded the Cleveland Clinic Innovator of the Year Award in both 2004 and 2005.

Dr. Navia has published many articles and abstracts in national and international professional publications on topics related to his surgical and research specialties, in addition to being a manuscript reviewer for The Annals of Thoracic Surgery. Dr. Navia organizes seminars and symposia on advanced topics in cardiothoracic surgery and presents his work at major international conferences with leading physicians from around the world.

Dr. Navia enjoys spending time with his family, especially when they are on the beaches of his native Argentina or skiing together in the winter.

Watch a video about Dr. Navia and his work performing video-assisted valve surgery.

Professional Highlights

  • Surgical Director, Center for Electrical Therapy in Heart Failure.
  • Manuscript reviewer for several medical journals such as, The Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, and The Argentine Society of Cardiology.

Education & Fellowships

Residency - Cleveland Clinic
Thoracic Surgery
Cleveland, OH USA
1996
Residency - Hospital General de Agudos, Italian Hospital
General Surgery
Buenos Aires, Argentina Argentina
1989
Internship - Hospital General de Agudos, Italian Hospital
Rotating Internship
Buenos Aires, Argentina Argentina
1985
Medical School - National University of La Plata
Buenos Aires Argentina
1984

Specialty Interests

adult acquired heart disease, minimally invasive, video-assisted cardiac surgery, off-pump coronary artery bypass surgery, mitral, aortic and tricuspid valve repair and replacement surgery, including bicuspid aortic valve repair and David Procedure; surgical treatment of valve endocarditis; cardiac reoperations; surgical electrical therapies for heart failure and arrhythmia surgery

Awards & Honors

  • Rene Favaloro International Fellow Award, 1994-1995.
  • Dr. Charles H. Bryan Clinical Excellence Award from Cleveland Clinic, Cardiothoracic Surgery,1996.
  • Cleveland Clinic Innovator Awards, 2004, 2005 and 2006.

Additional Training

  • HeartMate II® Left Ventricular Assist System.  Laboratory training program at Texas Heart Institute, Houston, TX   December 19-20,2005.
  • Robotic Cardiac Surgery. The Latest Technology Nano Medicine Summit. Cleveland Clinic. Cleveland, Ohio. October 25-26, 2005.
  • Surgical Treatment of Atrial Fibrillation. Is Ready For Prime Time. State of the Heart. A Cardiovascular Seminar For Nurses 2005. American Heart Association, Learn and Live. Cuyahoga Falls, Ohio. May 6, 2005.
  • Minimally Invasive Left Ventricular Epicardial Lead Placement:  Surgical Techniques for Heart Failure and Resynchronization Therapy:  Society of Thoracic Surgeons Annual Meeting.  San Antonio, Texas.  January 24 –January 28, 2004.
  • The Latest Technology-Robotic-Assisted Cardiac Surgery. Cleveland Clinic Health Talk-Innovations in Heart Surgery: Cleveland Clinic. Cleveland, Ohio 44195. February 26, 2003.

Innovations & Patents

  • Received a National Institutes of Health RO1 grant to develop robotic tools for off-pump coronary artery bypass surgery. 
  • Pioneered the design for incisions used during minimally invasive mitral valve repair surgery.
  • Holds several US patents including: Method of Implanting a Stentless Cardiac Valve Prosthesis Apparatus; Method for Auto-Retroprofusion of a Coronary Vein; and Method and Apparatus for Replacing a Mitral Valve with a Stentless Bioprosthetic Valve.
  • Four additional US patents applied for in 2007 are pending.

Memberships

  • The Society of Thoracic Surgeons
  • Minimally Invasive Robotic Association
  • American Medical Association
  • Heart Rhythm Society
  • American Heart Association

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/30/2014, Dr. Navia has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Navia receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Edwards Lifesciences LLC
  • Maquet Cardiovascular, LLC.

Royalty Payments. Dr. Navia receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • NaviGate Cardiac Structures, Inc.

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Navia may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

  • NaviGate Cardiac Structures, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Italian
  • Spanish